Diaphorina citri psyllid: psy7203

Annotation transfered from Closely Related SWISS-PROT Entries

Annotation	Function Description	Confidence Level	Reference Protein
COUP transcription factor 2	Ligand-activated transcription factor. Activated by high concentrations of 9-cis-retinoic acid and all-trans-retinoic acid, but not by dexamethasone, cortisol or progesterone (in vitro). Regulation of the apolipoprotein A-I gene transcription. Binds to DNA site A.	very confident	O09018
Steroid receptor seven-up, isoforms B/C	Receptor that is required in photoreceptors R1, R3, R4 and R6 during eye development; generation of the ganglion mother cell-2 (GMC-2) fate in the nb7-3 lineage, coinciding with the transition in the expression of HB to KR in the neuroblasts (NBs).	very confident	P16375
COUP transcription factor 2	Ligand-activated transcription factor. Activated by high concentrations of 9-cis-retinoic acid and all-trans-retinoic acid, but not by dexamethasone, cortisol or progesterone (in vitro). Regulation of the apolipoprotein A-I gene transcription. Binds to DNA site A.	very confident	Q9TTR7

Prediction of Gene Ontology Terms

GO Term	Description	Confidence Level	Parent GO Terms
GO:0001972 [MF]	retinoic acid binding	confident	GO:0043168, GO:0031406, GO:0019840, GO:0008289, GO:0043167, GO:0003674, GO:0005488, GO:0033293, GO:0005501
GO:0043565 [MF]	sequence-specific DNA binding	confident	GO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0000122 [BP]	negative regulation of transcription from RNA polymerase II promoter	confident	GO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0006357, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0045892, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0008150, GO:0010558, GO:0048523
GO:0007165 [BP]	signal transduction	confident	GO:0044700, GO:0051716, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0001764 [BP]	neuron migration	confident	GO:0040011, GO:0032502, GO:0048699, GO:0048856, GO:0044707, GO:0007399, GO:0048870, GO:0009987, GO:0048869, GO:0032501, GO:0030154, GO:0006928, GO:0008150, GO:0051674, GO:0044763, GO:0007275, GO:0048731, GO:0022008, GO:0016477, GO:0051179, GO:0044699
GO:0030900 [BP]	forebrain development	confident	GO:0032502, GO:0044707, GO:0007420, GO:0007399, GO:0032501, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699, GO:0007417
GO:0005634 [CC]	nucleus	confident	GO:0043231, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0044424, GO:0043227, GO:0043226
GO:0004879 [MF]	ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity	confident	GO:0038023, GO:0003700, GO:0060089, GO:0003674, GO:0004872, GO:0004871, GO:0000981, GO:0001071
GO:0045736 [BP]	negative regulation of cyclin-dependent protein serine/threonine kinase activity	confident	GO:0033673, GO:0043549, GO:0019220, GO:0080090, GO:0019222, GO:0044092, GO:0031324, GO:0031323, GO:0009892, GO:0071901, GO:0071900, GO:0043086, GO:0051248, GO:0045786, GO:0051348, GO:0051246, GO:0050789, GO:0065007, GO:0031399, GO:0048519, GO:0065009, GO:0006469, GO:0045936, GO:0060255, GO:0045859, GO:0050794, GO:0051174, GO:0032268, GO:0008150, GO:0010605, GO:0042325, GO:0032269, GO:0042326, GO:0050790, GO:0051726, GO:0010563, GO:0031400, GO:0051338, GO:0001933, GO:0001932, GO:0000079, GO:0048523
GO:0009566 [BP]	fertilization	probable	GO:0044702, GO:0000003, GO:0019953, GO:0022414, GO:0008150, GO:0044699
GO:0048514 [BP]	blood vessel morphogenesis	probable	GO:0032502, GO:0032501, GO:0044707, GO:0001568, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0032355 [BP]	response to estradiol stimulus	probable	GO:1901700, GO:0009719, GO:0033993, GO:0050896, GO:0008150, GO:0014070, GO:0009725, GO:0043627, GO:0042221, GO:0097305, GO:0010033, GO:0048545
GO:0010596 [BP]	negative regulation of endothelial cell migration	probable	GO:0030336, GO:0040013, GO:0030334, GO:0010594, GO:0010632, GO:0010633, GO:0065007, GO:0051271, GO:0040012, GO:0008150, GO:0051270, GO:2000145, GO:0051239, GO:2000146, GO:0048519, GO:0032879, GO:0050794, GO:0050789, GO:0048523
GO:0009956 [BP]	radial pattern formation	probable	GO:0032502, GO:0007389, GO:0032501, GO:0044707, GO:0008150, GO:0003002, GO:0007275, GO:0044699
GO:0009952 [BP]	anterior/posterior pattern specification	probable	GO:0032502, GO:0007389, GO:0032501, GO:0044707, GO:0008150, GO:0003002, GO:0007275, GO:0044699
GO:0003707 [MF]	steroid hormone receptor activity	probable	GO:0003674, GO:0038023, GO:0004872, GO:0004871, GO:0060089
GO:0003714 [MF]	transcription corepressor activity	probable	GO:0003674, GO:0003712, GO:0000989, GO:0000988
GO:0001893 [BP]	maternal placenta development	probable	GO:0060135, GO:0007275, GO:0044699, GO:0000003, GO:0048513, GO:0044706, GO:0032502, GO:0032501, GO:0048609, GO:0032504, GO:0044767, GO:0022414, GO:0008150, GO:0001890, GO:0051704, GO:0044703, GO:0044702, GO:0044707, GO:0003006, GO:0007565, GO:0048856, GO:0048731
GO:0007519 [BP]	skeletal muscle tissue development	probable	GO:0032502, GO:0007517, GO:0032501, GO:0044707, GO:0048856, GO:0009888, GO:0044767, GO:0061061, GO:0014706, GO:0048513, GO:0008150, GO:0060537, GO:0060538, GO:0048731, GO:0007275, GO:0044699
GO:0042803 [MF]	protein homodimerization activity	probable	GO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0004886 [MF]	9-cis retinoic acid receptor activity	probable	GO:0003708, GO:0038023, GO:0003700, GO:0001071, GO:0060089, GO:0003674, GO:0004879, GO:0004871, GO:0000981, GO:0004872
GO:0060707 [BP]	trophoblast giant cell differentiation	probable	GO:0048568, GO:0030154, GO:0009790, GO:0009792, GO:0007275, GO:0044699, GO:0001701, GO:0048869, GO:0048513, GO:0043009, GO:0032502, GO:0032501, GO:0060706, GO:0009987, GO:0044767, GO:0008150, GO:0048731, GO:0001892, GO:0001890, GO:0044707, GO:0048856, GO:0044763
GO:0060173 [BP]	limb development	probable	GO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0008150, GO:0044699, GO:0007275, GO:0048736
GO:0031641 [BP]	regulation of myelination	probable	GO:0051239, GO:0044057, GO:0031644, GO:0032844, GO:0008150, GO:0050793, GO:2000021, GO:2000026, GO:0051960, GO:0023051, GO:0065007, GO:0051969, GO:0010646, GO:0050789, GO:0050794
GO:0045944 [BP]	positive regulation of transcription from RNA polymerase II promoter	probable	GO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0060674 [BP]	placenta blood vessel development	probable	GO:0032502, GO:0032501, GO:0044707, GO:0072358, GO:0001568, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0048513, GO:0008150, GO:0044699, GO:0048731, GO:0007275, GO:0001890
GO:0008270 [MF]	zinc ion binding	probable	GO:0043169, GO:0046914, GO:0043167, GO:0003674, GO:0005488, GO:0046872
GO:0060849 [BP]	regulation of transcription involved in lymphatic endothelial cell fate commitment	probable	GO:0051252, GO:0080090, GO:0019222, GO:2000112, GO:0030154, GO:0031323, GO:0031326, GO:0072359, GO:0072358, GO:0045446, GO:0007275, GO:0044699, GO:0003158, GO:0001944, GO:0001945, GO:0050789, GO:0019219, GO:0060850, GO:0065007, GO:0060836, GO:0030855, GO:0060839, GO:0010468, GO:0032502, GO:0009987, GO:0010556, GO:0060255, GO:0032501, GO:0060429, GO:0009889, GO:0009888, GO:0050794, GO:0044767, GO:0008150, GO:0051171, GO:0072148, GO:2001141, GO:0045165, GO:0044707, GO:0048856, GO:0044763, GO:0060838, GO:0006355, GO:0006357, GO:0048869, GO:0048731
GO:0001937 [BP]	negative regulation of endothelial cell proliferation	probable	GO:0042127, GO:0008285, GO:0050678, GO:0050680, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523, GO:0001936
GO:0044323 [MF]	retinoic acid-responsive element binding	probable	GO:0044212, GO:0097159, GO:0000975, GO:0001067, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0044255 [BP]	cellular lipid metabolic process	probable	GO:0044238, GO:0044710, GO:0006629, GO:0009987, GO:0044237, GO:0071704, GO:0008150, GO:0008152
GO:0031490 [MF]	chromatin DNA binding	probable	GO:0043566, GO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:0003682, GO:1901363
GO:0048384 [BP]	retinoic acid receptor signaling pathway	probable	GO:0044700, GO:0051716, GO:0030522, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0019048 [BP]	virus-host interaction	probable	GO:0044419, GO:0044703, GO:0000003, GO:0009987, GO:0022415, GO:0022414, GO:0044764, GO:0008150, GO:0016032, GO:0044403, GO:0051701, GO:0051704
GO:0048666 [BP]	neuron development	probable	GO:0032502, GO:0048699, GO:0048856, GO:0007399, GO:0030182, GO:0009987, GO:0048869, GO:0030154, GO:0048468, GO:0044767, GO:0032501, GO:0044763, GO:0048731, GO:0008150, GO:0022008, GO:0007275, GO:0044699, GO:0044707
GO:0046966 [MF]	thyroid hormone receptor binding	probable	GO:0008134, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0000790 [CC]	nuclear chromatin	probable	GO:0031974, GO:0043229, GO:0043228, GO:0000785, GO:0000228, GO:0043227, GO:0043226, GO:0044446, GO:0031981, GO:0005634, GO:0044454, GO:0005694, GO:0043231, GO:0043232, GO:0043233, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0070013, GO:0044428, GO:0044424, GO:0044427, GO:0044422
GO:0043401 [BP]	steroid hormone mediated signaling pathway	probable	GO:0071383, GO:0023052, GO:0007165, GO:0070887, GO:0042221, GO:0050789, GO:0044699, GO:0009755, GO:0051716, GO:0033993, GO:0071310, GO:0065007, GO:0014070, GO:0071495, GO:0009719, GO:0009987, GO:0071396, GO:0050794, GO:0032870, GO:0044763, GO:0007154, GO:0010033, GO:0044700, GO:0071407, GO:0050896, GO:0009725, GO:0008150, GO:0048545
GO:0006367 [BP]	transcription initiation from RNA polymerase II promoter	probable	GO:0032774, GO:0090304, GO:0044249, GO:0034641, GO:0006807, GO:0034645, GO:1901362, GO:1901360, GO:1901576, GO:0044260, GO:0071704, GO:0010467, GO:0006366, GO:0018130, GO:0006139, GO:0009987, GO:0006725, GO:0009058, GO:0009059, GO:0008150, GO:0008152, GO:0034654, GO:0046483, GO:0016070, GO:0044238, GO:0044271, GO:0044237, GO:0043170, GO:0006351, GO:0006352, GO:0019438
GO:0043153 [BP]	entrainment of circadian clock by photoperiod	probable	GO:0009628, GO:0009605, GO:0009314, GO:0050896, GO:0042752, GO:0065007, GO:0009416, GO:0009649, GO:0009648, GO:0008150, GO:0050789
GO:0046982 [MF]	protein heterodimerization activity	probable	GO:0046983, GO:0003674, GO:0005488, GO:0005515
GO:0032403 [MF]	protein complex binding	probable	GO:0003674, GO:0005488, GO:0005515
GO:0048738 [BP]	cardiac muscle tissue development	probable	GO:0032502, GO:0007507, GO:0032501, GO:0044707, GO:0048513, GO:0048856, GO:0072359, GO:0009888, GO:0044767, GO:0014706, GO:0072358, GO:0008150, GO:0060537, GO:0048731, GO:0007275, GO:0044699
GO:0071300 [BP]	cellular response to retinoic acid	probable	GO:1901700, GO:1901701, GO:0032526, GO:0033993, GO:0050896, GO:0009987, GO:0071396, GO:0051716, GO:0008150, GO:0071310, GO:0044763, GO:0070887, GO:0042221, GO:0010033, GO:0044699
GO:0030424 [CC]	axon	probable	GO:0044464, GO:0005623, GO:0005575, GO:0097458, GO:0043005, GO:0042995
GO:0030375 [MF]	thyroid hormone receptor coactivator activity	probable	GO:0030545, GO:0030546, GO:0003713, GO:0003712, GO:0030374, GO:0003674, GO:0000989, GO:0000988, GO:0010861
GO:0042809 [MF]	vitamin D receptor binding	probable	GO:0008134, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0003690 [MF]	double-stranded DNA binding	probable	GO:0043566, GO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0004887 [MF]	thyroid hormone receptor activity	probable	GO:0038023, GO:0003700, GO:0001071, GO:0060089, GO:0003674, GO:0004879, GO:0004871, GO:0000981, GO:0004872
GO:0070644 [MF]	vitamin D response element binding	probable	GO:0044212, GO:0097159, GO:0000975, GO:0001067, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0042974 [MF]	retinoic acid receptor binding	probable	GO:0008134, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0005667 [CC]	transcription factor complex	probable	GO:0043234, GO:0044446, GO:0032991, GO:0005575, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0005654, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0044424, GO:0044451, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0065008 [BP]	regulation of biological quality	probable	GO:0008150, GO:0065007
GO:0000982 [MF]	RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity	probable	GO:0003700, GO:0003674, GO:0001071, GO:0000981
GO:0005737 [CC]	cytoplasm	probable	GO:0044424, GO:0005575, GO:0044464, GO:0005623, GO:0005622
GO:0050965 [BP]	detection of temperature stimulus involved in sensory perception of pain	probable	GO:0050961, GO:0009582, GO:0009628, GO:0051606, GO:0016048, GO:0009605, GO:0009581, GO:0050877, GO:0050896, GO:0050951, GO:0007600, GO:0032501, GO:0050906, GO:0009266, GO:0019233, GO:0008150, GO:0044707, GO:0044699, GO:0003008
GO:0048583 [BP]	regulation of response to stimulus	probable	GO:0008150, GO:0065007, GO:0050789
GO:0035357 [BP]	peroxisome proliferator activated receptor signaling pathway	probable	GO:0044700, GO:0051716, GO:0030522, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0001946 [BP]	lymphangiogenesis	probable	GO:0032502, GO:0036303, GO:0044707, GO:0032501, GO:0048856, GO:0001944, GO:0001945, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0010977 [BP]	negative regulation of neuron projection development	probable	GO:0010975, GO:0030154, GO:0051129, GO:0051128, GO:0031345, GO:0050789, GO:0044699, GO:0050767, GO:0048869, GO:0060284, GO:0031344, GO:0045664, GO:0065007, GO:0048519, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045595, GO:0008150, GO:0051239, GO:0048731, GO:0022008, GO:0048699, GO:0044707, GO:0007399, GO:0048856, GO:0051960, GO:2000026, GO:0007275, GO:0044763, GO:0048523

Prediction of Enzyme Commission Number

No EC number assigned to the protein, probably not an enzyme!

Spatial Structural Prediction